Uranus Chemicals Co., LTD. (TPEX:7742)
64.90
-7.10 (-9.86%)
At close: Jul 29, 2026
TPEX:7742 Revenue
In the year 2025, Uranus Chemicals Co., LTD. had annual revenue of 1.17B TWD with 42.43% growth. Uranus Chemicals Co., LTD. had revenue of 871.68M in the half year ending December 31, 2025, with 122.56% growth.
Revenue
1.17B
Revenue Growth
+42.43%
P/S Ratio
5.22
Revenue / Employee
10.84M
Employees
108
Market Cap
6.11B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | 348.74M | 42.43% |
| Dec 31, 2024 | 821.91M | 95.62M | 13.17% |
| Dec 31, 2023 | 726.29M | -591.46M | -44.88% |
| Dec 31, 2022 | 1.32B | 323.82M | 32.58% |
| Dec 31, 2021 | 993.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tatung System Technologies | 5.27B |
| Hi-Clearance | 4.37B |
| Franbo Lines | 2.47B |
| Promate Solutions | 2.08B |
| Zen Voce | 1.62B |
| Progate Group | 1.52B |
| TacBright Optronics | 1.21B |
| Grand Fortune Securities Co.,Ltd | 1.13B |